scholarly journals Exploration of real‐world outcomes and treatment patterns in patients treated with anti‐vascular endothelial growth factors for neovascular age‐related macular degeneration in Sweden

2021 ◽  
Author(s):  
Marion Schroeder ◽  
Inger Westborg ◽  
Caroline Fluur ◽  
Rasmus Olsen ◽  
Monica Lövestam‐Adrian
2019 ◽  
Vol 4 (1) ◽  

Age related macular degeneration has been the leading cause of blindness in industrialized countries. Various treatments have been developed in the last few years. The pinnacle of treatment of neovascular age related macular degenerations have been anti-vascular endothelial growth factors. This article is an opinion on macular atrophy developing in neovascular age related macular degeneration.


Sign in / Sign up

Export Citation Format

Share Document